Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Response

Dr Peter Robson
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.15-1-106d
Clin Med February 2015
Dr Peter Robson
AClatterbridge Cancer Centre Liverpool, UK
Roles: Consultant clinical oncologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Editor – My thanks to Dr Murray-Brown for raising this important issue. In my article ‘Metastatic spinal cord compression: a rare but important complication of cancer’ I concentrated primarily on the presentation and initial management of these cases. In the short section on rehabilitation I did not discuss the reduction of steroids and I agree that this is a very important part of the management.

In metastatic spinal cord compression patients the high dose steroids are used to reduce swelling and neurological symptoms whilst they start their definitive treatment. In our practice, once patients have commenced their fractionated radiotherapy treatment we reduce the steroids rapidly by half every two days. Most patients will have stopped taking their steroids just after their discharge on completion of radiotherapy treatment. Occasional patients require longer term treatment to control symptoms but this is kept at the lowest dose possible. If the patient deteriorates on reduction then higher doses are resumed short term to try to improve their symptoms.

I agree that patients who are not fit enough for definitive treatment, or who have received a single fraction of radiotherapy should have their steroids reduced gradually. Ideally they should be reduced gradually and then stopped over a 3–4 week period, or reduced and then maintained at the lowest possible dose at which their symptoms are controlled.

  • © 2015 Royal College of Physicians
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Response
Dr Peter Robson
Clinical Medicine Feb 2015, 15 (1) 106; DOI: 10.7861/clinmedicine.15-1-106d

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Response
Dr Peter Robson
Clinical Medicine Feb 2015, 15 (1) 106; DOI: 10.7861/clinmedicine.15-1-106d
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides
  • Response
  • Functional disorders and chronic pain
Show more Letters to the editor

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians